Maastricht University

EQS-News: Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board

Retrieved on: 
수요일, 4월 10, 2024

Berlin, Germany, 3 April 2024 – Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.

Key Points: 
  • Berlin, Germany, 3 April 2024 – Berlin Cures, a biotechnology company in Phase II clinical trial for a treatment against Long COVID, appoints six distinguished scientists to a new advisory board.
  • The aim of the board is to advise on industry developments and new growth potentials, as well as to support research and development that will further strengthen the portfolio of Berlin Cures and thus the successful market launch of new therapies.
  • “We are very pleased to now work with six renowned scientists who have achieved great success in their respective fields of research.
  • Berlin Cures has been known for innovative and effective research for years.

Entire industries vs specific stocks: What are the factors that impact investors’ judgment?

Retrieved on: 
수요일, 3월 13, 2024

Cambridge, MA, March 13, 2024 (GLOBE NEWSWIRE) -- Entire industries vs specific stocks: What are the factors that impact investors’ judgment?

Key Points: 
  • Cambridge, MA, March 13, 2024 (GLOBE NEWSWIRE) -- Entire industries vs specific stocks: What are the factors that impact investors’ judgment?
  • Money managers should recognize that their clients are more likely to be thinking about broad categories of stocks when distracted by world events.
  • Accordingly, previous work has shown that successful managers time the market well in recessions and pick stocks well in booms.
  • Bhui and Jiao analyzed how long subjects moused over different options, such as information about the industry as a whole or specific stocks.

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)

Retrieved on: 
수요일, 2월 28, 2024

The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024.

Key Points: 
  • The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024.
  • Ms. Hanneman will join Philips as a member of Philips’ Executive Committee on June 1, 2024, to start her induction and transition into the role, succeeding current CFO Abhijit Bhattacharya on October 1, 2024.
  • In this current role, she is responsible for financial control, enterprise financial planning and analysis, and business development finance.
  • I am fully focused on delivering on Philips’ plan in the next six months and ensuring a seamless handover to Charlotte.”

Erasmus Prize 2024 awarded to Amitav Ghosh

Retrieved on: 
목요일, 3월 7, 2024

AMSTERDAM, March 7, 2024 /PRNewswire/ -- The Praemium Erasmianum Foundation has awarded the Erasmus Prize 2024 to the Indian writer Amitav Ghosh.

Key Points: 
  • AMSTERDAM, March 7, 2024 /PRNewswire/ -- The Praemium Erasmianum Foundation has awarded the Erasmus Prize 2024 to the Indian writer Amitav Ghosh.
  • Ghosh has won various prizes, among them the 2018 Jnanpith Award, the highest literary prize in India.
  • The Erasmus Prize is awarded annually to an individual or institution that has made an exceptional contribution to the field of humanities or the arts.
  • The Erasmus Prize consists of € 150,000 in prize money.

Erasmus Prize 2024 awarded to Amitav Ghosh

Retrieved on: 
목요일, 3월 7, 2024

AMSTERDAM, March 7, 2024 /PRNewswire/ -- The Praemium Erasmianum Foundation has awarded the Erasmus Prize 2024 to the Indian writer Amitav Ghosh.

Key Points: 
  • AMSTERDAM, March 7, 2024 /PRNewswire/ -- The Praemium Erasmianum Foundation has awarded the Erasmus Prize 2024 to the Indian writer Amitav Ghosh.
  • Ghosh has won various prizes, among them the 2018 Jnanpith Award, the highest literary prize in India.
  • The Erasmus Prize is awarded annually to an individual or institution that has made an exceptional contribution to the field of humanities or the arts.
  • The Erasmus Prize consists of € 150,000 in prize money.

Matter Neuroscience Secures $26M in Funding to Cure Unhappiness

Retrieved on: 
화요일, 2월 27, 2024

NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Matter Neuroscience, the company working to unlock a deeper understanding of happiness and well-being by providing people with personalized insights into their brain chemistry emerges from stealth mode today. Matter announced it has received $26 million in funding, initial funding seeded by Polaris Partners and a more recent round co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures, and joined by Collaborative Fund and others. With this backing, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.

Key Points: 
  • With this backing, Matter will bolster its efforts to pioneer solutions that address the unhappiness epidemic by transforming our understanding and management of mental well-being.
  • Together with its collaboration partners, Matter Neuroscience will initiate three more clinical studies in 2024.
  • Matter also offers users access to educational materials and a lecture series on the neuroscience of happiness.
  • Matter Neuroscience was co-founded in 2019 with Ben Goldhirsh of GOOD Worldwide and the Goldhirsh Foundation, and Chris Shiflett of Faculty and Brooklyn Beta.

Longer-Term Nut Consumption Improves Brain Insulin Sensitivity, New Study Finds

Retrieved on: 
목요일, 2월 1, 2024

BARCELONA, Spain , Feb. 1, 2024 /PRNewswire/ -- Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that, for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity. This may be important for the prevention of age-related metabolic and cognitive diseases.

Key Points: 
  • The study showed that, for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity.
  • Cerebral blood flow (CBF) was quantified using magnetic resonance imaging (MRI), while brain insulin sensitivity was assessed by measuring regional CBF responses to intranasal insulin.
  • The study found that nut consumption significantly improved insulin action in (occipital and frontal) brain regions involved in the modulation of metabolic and cognitive processes.
  • However, intrahepatic lipid content, serum LDL ("bad") cholesterol and systolic blood pressure were lower following nut consumption compared to the control period.

Improving Anti-SLAPP Defense : PATFox Project Takes Centre-Stage at the European Parliament

Retrieved on: 
목요일, 1월 25, 2024

On 31 January 2024, from 9:00 to 11:00 CET, the conference "Improving Anti-SLAPP Defence: Lessons learned from the PATFox Project" will take place at the European Parliament, Room ASP 5G1.

Key Points: 
  • On 31 January 2024, from 9:00 to 11:00 CET, the conference "Improving Anti-SLAPP Defence: Lessons learned from the PATFox Project" will take place at the European Parliament, Room ASP 5G1.
  • The event celebrates the closing of the European project PATFox project, aimed at training legal professionals from 11 European countries in anti-SLAPP defense.
  • The event will bring together the PATFox consortium partners to present the main achievements and legacy of the project.
  • Registration for the event is mandatory and can be done online through this link by Friday 26th: https://forms.gle/BcxJt4mAPCg2fdoP7
    More information about the PATFox project at: www.antislapp.eu/

Longer-Term Nut Consumption Improves Brain Insulin Sensitivity, New Study Finds

Retrieved on: 
화요일, 1월 16, 2024

BARCELONA, Spain, Jan. 16, 2024 /PRNewswire/ -- Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity. This may be important for the prevention of age-related metabolic and cognitive diseases.

Key Points: 
  • The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity.
  • Cerebral blood flow (CBF) was quantified using magnetic resonance imaging (MRI), while brain insulin sensitivity was assessed by measuring regional CBF responses to intranasal insulin.
  • The study found that nut consumption significantly improved insulin action in (occipital and frontal) brain regions involved in the modulation of metabolic and cognitive processes.
  • However, intrahepatic lipid content, serum LDL ('bad') cholesterol and systolic blood pressure were lower following nut consumption compared to the control period.

Longer-Term Nut Consumption Improves Brain Insulin Sensitivity, New Study Finds

Retrieved on: 
화요일, 1월 16, 2024

BARCELONA, Spain, Jan. 16, 2024 /PRNewswire/ -- Results from a recent INC-funded intervention study were published in the American Journal of Clinical Nutrition [1]. The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity. This may be important for the prevention of age-related metabolic and cognitive diseases.

Key Points: 
  • The study showed that for older adults with overweight or obesity, longer-term consumption of mixed nuts significantly improved brain insulin sensitivity.
  • Cerebral blood flow (CBF) was quantified using magnetic resonance imaging (MRI), while brain insulin sensitivity was assessed by measuring regional CBF responses to intranasal insulin.
  • The study found that nut consumption significantly improved insulin action in (occipital and frontal) brain regions involved in the modulation of metabolic and cognitive processes.
  • However, intrahepatic lipid content, serum LDL ('bad') cholesterol and systolic blood pressure were lower following nut consumption compared to the control period.